甲状腺功能与心境障碍:孟德尔随机化研究
该研究采用两样本孟德尔随机化方法,利用大规模全基因组关联研究数据,探讨正常范围内促甲状腺激素(TSH)和游离甲状腺素(fT4)水平的微小变化对重度抑郁症(MDD)和双相障碍(BD)风险的因果效应。结果显示,遗传预测的TSH和fT4水平与MDD风险及其亚型、轻微抑郁症状均无关联;fT4每升高1个标准差与BD总体风险降低11%名义相关(OR=0.89,95%CI 0.80-0.98,p=0.022),与BD 1型风险降低13%名义相关(OR=0.87,95%CI 0.75-1.00,p=0.047)。反向MR未发现MDD或BD遗传易感性对TSH或fT4水平的影响。
要点
- 正常范围内TSH和fT4的微小变化对MDD风险及其亚型、轻微抑郁症状无因果效应。
- fT4每升高1个标准差与BD风险降低11%名义相关,与BD 1型风险降低13%名义相关。
- MDD和BD的遗传易感性未发现影响TSH或fT4水平。
核心结论
- 正常范围内TSH和fT4水平的微小变化对MDD风险及其亚型、轻微抑郁症状无因果效应,抑郁症状不应归因于甲状腺功能的微小变化。
- fT4水平与BD及BD 1型风险存在边界性关联,提示需进一步临床研究探讨甲状腺激素治疗在BD中的作用。
研究设计与样本
- 采用两样本孟德尔随机化分析,使用正常范围TSH(n=54,288)和fT4(n=49,269)水平的全基因组关联研究数据。
- MDD数据包含170,756例病例和329,443例对照,BD数据包含20,352例病例和31,358例对照。
- 次要MR分析评估TSH和fT4对MDD和BD特定亚型的影响,并进行了反向MR分析。
主要发现
- 遗传预测的TSH和fT4水平与MDD风险、MDD亚型及轻微抑郁症状均无关联。
- fT4每升高1个标准差与BD总体风险降低11%名义相关(OR=0.89,95%CI 0.80-0.98,p=0.022)。
- fT4每升高1个标准差与BD 1型风险降低13%名义相关(OR=0.87,95%CI 0.75-1.00,p=0.047)。
- 反向MR显示MDD和BD的遗传易感性与TSH或fT4水平无关。
临床怎么用
- 抑郁症状不应常规归因于正常范围内的甲状腺功能微小变异。
- 对于双相障碍患者,甲状腺激素治疗的潜在效应值得进一步临床研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Observational studies suggest that even minor variations in thyroid function are associated with the risk of mood disorders, including major depressive disorder (MDD) and bipolar disorder (BD). However, it is unknown whether these associations are causal or not. We used a Mendelian randomization (MR) approach to investigate causal effects of minor variations in thyrotropin (TSH) and free thyroxine (fT4) levels on MDD and BD risk. Materials and Methods: We performed two-sample MR analyses using data from the largest publicly available genome-wide association studies on normal-range TSH (n = 54,288) and fT4 (n = 49,269) levels, MDD (170,756 cases, 329,443 controls) and BD (20,352 cases, 31,358 controls). Secondary MR analyses investigated the effects of TSH and fT4 levels on specific MDD and BD subtypes. Reverse MR was also performed to assess the effects of MDD and BD on TSH and fT4 levels. Results: There were no associations between genetically predicted TSH and fT4 levels and MDD risk, nor MDD subtypes and minor depressive symptoms. A one standard deviation increase in fT4 levels was nominally associated with an 11% decrease in the overall BD risk (odds ratio [OR] = 0.89, 95% confidence interval [CI] = 0.80-0.98, p = 0.022) and a 13% decrease in the BD type 1 risk (OR = 0.87, CI = 0.75-1.00, p = 0.047). In the reverse direction, genetic predisposition to MDD and BD was not associated with TSH nor fT4 levels. Conclusions: Variations in normal-range TSH and fT4 levels have no effects on the risk of MDD and its subtypes, and neither on minor depressive symptoms. This indicates that depressive symptoms should not be attributed to minor variations in thyroid function. Borderline associations with BD and BD type 1 risks suggest that further clinical studies should investigate the effect of thyroid hormone treatment in BD.
引用
- Kuś A, Kjaergaard AD, Marouli E, et al. Thyroid Function and Mood Disorders: A Mendelian Randomization Study. Thyroid. 2021. PMID: 33899528. doi:10.1089/thy.2020.0884
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。